
    
      An estimated 75 patients (age 18 years of age or older) will be enrolled from the population
      of patients who present for ultrasound-guided radiofrequency ablation (RFA) of CT or
      MRI-confirmed multiple primary hepatocellular carcinoma (HCC) or metastatic carcinoma, with
      at least one of the tumors being â‰¤ 1.5 cm in diameter.
    
  